Key findings to develop a vaccine against Toxoplasma
Thursday, October 29, 2015 - 14:20
in Health & Medicine
A group of researchers has found that p62, a host molecule, played an important role in exerting immune effects of an experimental pathogenic parasite toxoplasma-inactivated vaccine. This group's achievement is expected to offer strategies for developing a toxoplasma-inactivated vaccine targeting p62 for treating toxoplasmosis.